跳至主要内容
临床试验/NCT02920411
NCT02920411已完成不适用

Estudio Piloto Sobre la Efectividad de la acción Conjunta de Una Crema Corporal y un bálsamo Corporal en niños Con Dermatitis atópica

Laboratorios Ordesa4 个研究点 分布在 1 个国家目标入组 43 人开始时间: 2016年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
43
试验地点
4
主要终点
Changes in Atopic Dermatitis severity according SCORAD test

研究概览

简要总结

The purpose of this study is to determine the effectiveness of a combined dermatological treatment in children up to 5 years old with mild or moderated atopic dermatitis.

详细描述

The intensive cream and body lotion of the PediATOPIC® products are two emollients expressly formulated to serve as adjuvants in the management of Atopic Dermatitis. Both products contain Dermosense complex®, a complex that includes 3 products: Bodyfensine peptide® (inductor of dephensine synthesis against microbial aggressions), Unimoist® (the mimetizing complex of the skin's natural hydration factor), and Ramnosoft® (polysaccharide that inhibits the adhesion of pro-inflammatory drugs and bacteria, while limiting the spread of inflammatory reactions in skin cells). They also contain Bisabolol, (plant extract with anti-inflammatory, anti-irritant and antimicrobial properties) and Panthenol (Pro vitamin B5 that accelerates the skin's natural regeneration process).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
1 Month 至 5 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Children from 1 month to 5 years old
  • Patients with atopic dermatitis mild-moderate with an SCORAD=16-40

排除标准

  • Other dermatological diseases that could interfere with the study results
  • Corticoids use during 3 weeks prior to the study
  • Antibiotics use to treat atopic dermatitis during 3 weeks prior to the study
  • Use of topical immunomodulators
  • Concurrent use of other emollients

研究组 & 干预措施

Combined dermatological treatment

Experimental

A combined treatment of two emollient products will be applied:

  • Pediatopic treatment cream during acute stages of atopic dermatitis and
  • Pediatopic body lotion during stable stages

干预措施: Pediatopic Treatment Cream (Other)

Combined dermatological treatment

Experimental

A combined treatment of two emollient products will be applied:

  • Pediatopic treatment cream during acute stages of atopic dermatitis and
  • Pediatopic body lotion during stable stages

干预措施: Pediatopic Body lotion (Other)

结局指标

主要结局

Changes in Atopic Dermatitis severity according SCORAD test

时间窗: At 15 days

\<16 mild; \>16\<40 moderate; \>40 severe

次要结局

  • Number of atopic dermatitis outbreaks(At 5 months)
  • Duration of stable periods (between outbreaks)(At 5 months)
  • Patient satisfaction assessed by Visual Analog Scales(At 5 months)
  • Treatment compliance assessed by Morisky-Green test(At 5 months)

研究者

发起方
Laboratorios Ordesa
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验

Effectiveness of a Combined Dermatological Treatment... | 临床试验